Question 1

Does Vident Advisory own CORT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Vident Advisory holds 10,338 shares of CORT (Corcept Therapeutics), worth $898,889.

Question 2

How many shares of CORT does Vident Advisory own?

Accepted Answer

As of its Q2 2026 13F, Vident Advisory holds 10,338 shares of CORT (Corcept Therapeutics).

Question 3

What is Vident Advisory's CORT position worth?

Accepted Answer

As of its Q2 2026 13F, Vident Advisory's CORT position is worth $898,889.

Question 4

Is Vident Advisory buying or selling CORT?

Accepted Answer

In Q2 2026, Vident Advisory reduced its CORT position by 2,164 shares (-17.3%).

Question 5

When did Vident Advisory first buy CORT?

Accepted Answer

Vident Advisory already held CORT in its Q3 2023 13F, the earliest on record, and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2026-Q2 Latest	Decreased	10,338	-17.3%	$898,889	0.0%	$86.95
2026-Q1	Decreased	12,502	-15.6%	$503,955	0.0%	$40.31
2025-Q4	Decreased	14,811	-12.5%	$515,423	0.0%	$34.80
2025-Q3	Decreased	16,925	-14.9%	$1.4M	0.0%	$83.11
2025-Q2	Decreased	19,896	-69.2%	$1.5M	0.0%	$73.40
2025-Q1	Decreased	64,594	-41.2%	$7.4M	0.1%	$114.22
2024-Q4	Decreased	109,778	-5.3%	$5.5M	0.1%	$50.39
2024-Q3	Decreased	115,892	-37.7%	$5.4M	0.1%	$46.28